ReposiTrak Files 2024 10-K: Assets $18.3M, Liabilities $0.6M

TL;DR

ReposiTrak 10-K filed: $18.3M assets, $0.6M liabilities. Solid financials.

AI Summary

ReposiTrak, Inc. filed its 10-K for the fiscal year ending June 30, 2024. The company reported total assets of $18,309,051 and total liabilities of $616,470. Key financial figures include $30,000,000 in authorized shares and $700,000 in paid-in capital. The filing also details contract asset balances as of June 30, 2024, amounting to $181,680 current and $108,052 long-term.

Why It Matters

This 10-K filing provides a comprehensive overview of ReposiTrak's financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — The filing is a standard annual report with no immediate red flags or significant negative disclosures.

Key Numbers

• $18.3B — Total Assets (Represents the company's total resources as of June 30, 2024.)
• $0.6M — Total Liabilities (Indicates the company's total obligations as of June 30, 2024.)
• $30.0M — Authorized Shares (The maximum number of shares the company is permitted to issue.)
• $0.7M — Paid-in Capital (Capital contributed by shareholders in exchange for stock.)
• $181,680 — Current Contract Asset (Represents a current asset related to contracts as of June 30, 2024.)

Key Players & Entities

• ReposiTrak, Inc. (company) — Filer of the 10-K
• June 30, 2024 (date) — Fiscal year end
• $18,309,051 (dollar_amount) — Total assets
• $616,470 (dollar_amount) — Total liabilities
• $30,000,000 (dollar_amount) — Authorized shares
• $700,000 (dollar_amount) — Paid-in capital
• Mr. Fields (person) — Chairman and Chief Executive Officer

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 Par Value TRAK New York Stock Excha
• $10.01 — ly $ 112,885,000 (at a closing price of $10.01 per share). As of September 30, 2024,
• $0.0165 — s declared a quarterly cash dividend of $0.0165 per share ($0.066 per year), payable to
• $0.066 — rly cash dividend of $0.0165 per share ($0.066 per year), payable to shareholders of r
• $10.70 — -1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resu
• $8,964,214 — lting in an aggregate purchase price of $8,964,214 (the " Preferred Redemption "). The Pre
• $95,284 — retired, for aggregate consideration of $95,284 and $2,272,701 in the case of Series B
• $2,272,701 — aggregate consideration of $95,284 and $2,272,701 in the case of Series B Preferred and S

Filing Documents

• trak20240630c_10k.htm (10-K) — 1483KB
• ex_685297.htm (EX-23.1) — 3KB
• ex_685298.htm (EX-31.1) — 11KB
• ex_685299.htm (EX-31.2) — 11KB
• ex_685300.htm (EX-32.1) — 6KB
• ex_727199.htm (EX-97) — 27KB
• b01.jpg (GRAPHIC) — 10KB
• b02.jpg (GRAPHIC) — 11KB
• b03.jpg (GRAPHIC) — 4KB
• 0001437749-24-030271.txt ( ) — 7347KB
• trak-20240630.xsd (EX-101.SCH) — 63KB
• trak-20240630_cal.xml (EX-101.CAL) — 46KB
• trak-20240630_def.xml (EX-101.DEF) — 416KB
• trak-20240630_lab.xml (EX-101.LAB) — 379KB
• trak-20240630_pre.xml (EX-101.PRE) — 457KB
• trak20240630c_10k_htm.xml (XML) — 1145KB

Business

Business 2 Item 1A.

Risk Factors

Risk Factors 6 Item 1B. Unresolved Staff Comments 13 Item 1C. Cybersecurity 13 Item 2.

Properties

Properties 13 Item 3.

Legal Proceedings

Legal Proceedings 13 Item 4. Mine Safety Disclosures 13 PART II Item 5. Market for Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 13 Item 6.

Selected Financial Data

Selected Financial Data 15 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 23 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 23 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 23 Item 9A.

Controls and Procedures

Controls and Procedures 23 Item 9B. Other Information 24 Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections 24 PART III Item 10. Directors, Executive Officers and Corporate Governance 24 Item 11.

Executive Compensation

Executive Compensation 24 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 24 Item 13. Certain Relationships and Related Transactions, and Director Independence 24 Item 14. Principal Accounting Fees and Services 24 PART IV Item 15. Exhibits, Financial Statement Schedules 24

Signatures

Signatures 27 Report of Independent Registered Public Accounting Firm F-1 Consolidated Balance Sheets as of June 30, 2024 and 2023 F-3 Consolidated Statements of Operations for the Years Ended June 30, 2024 and 2023 F-4 Consolidated Statements of Stockholders' Equity (Deficit) for the Years Ended June 30, 2024 and 2023 F-5 Consolidated Statements of Cash Flows for the Years Ended June 30, 2024 and 2023 F-6

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements F-7 Exhibit 31 Certifications of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Exhibit 32 Certifications pursuant to 18 U.S.C. Sec. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K (this " Annual Report " ) contains forward-looking statements. The words or phrases " would be, " " will allow, " " intends to, " " will likely result, " " are expected to, " " will continue, " " is anticipated, " " estimate, " " project, " or similar expressions are intended to identify " forward-looking statements. " Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties, including the risk factors set forth below and elsewhere in this Annual Report. See " Risk Factors " and " Management ' s Discussion and Analysis of Financial Condition and Results of Operations. " Statements made herein are as of the date of the filing of this Annual Report with the Securities and Exchange Commission and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we do not undertake, and specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. 1 Table of Contents PART I ITEM I.

BUSINESS

BUSINESS Overview ReposiTrak, Inc., a Nevada corporation (" ReposiTrak ", " We ", " us ", "our" or the " Company ") is a Software-as-a-Service (" SaaS ") which operates a business-to-business (" B2B ") e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies. The Company's services are grouped in three application suites: 1. ReposiTrak Compliance Management (" Compliance ") solutions, which helps the Company's customers vet suppliers and reduce a company's potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (" FSMA "); 2. ReposiTrak Traceability Network (" Traceability " or " RTN "), which helps the Company's customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (" KDEs ") now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each event' known as a critical tracking event' or "CTE", which includes tracking from farm to shelf; and 3. ReposiTrak Supply Chain Solutions (" Supply Chain "), which help the Company's customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their s

View Full Filing

View this 10-K filing on SEC EDGAR